IMV

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IMV and buy or sell other stocks, options, and ETFs commission-free!

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. 

CEO
Andrew Hall
CEOAndrew Hall
Employees
Employees
Headquarters
Dartmouth, Nova Scotia
HeadquartersDartmouth, Nova Scotia
Founded
2007
Founded2007
Employees
Employees

IMV Key Statistics

Market cap
7.86M
Market cap7.86M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
0.10
Average volume0.10
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.00
52 Week high$1.00
52 Week low
52 Week low
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.